Press-release for stocks

Prices are updated after-hours

therapeutics crawled date : 2021 - 09 - 29

save search

594VH, Associate Director / Senior Manager, R&D Finance
Published: 2021-09-29 (Crawled : 22:00) - fatetherapeutics.com
FATE | $5.28 -1.86% -1.89% 2.1M

Health Technology

| -91.0% | O: 0.55% H: 1.01% C: -1.43%

4D Molecular Therapeutics to Participate in Chardan’s 5th Annual Genetic Medicines Conference
Published: 2021-09-29 (Crawled : 21:00) - biospace.com/
FDMT | $25.3 -5.42% -5.73% 520K

Health Technology

| -11.95% | O: 0.92% H: 0.41% C: -8.94%
genetic molecular conference

Seres Therapeutics Presents Data Supporting its Microbiome Pipeline at IDWeek 2021, Including Data from SER-109 Phase 3 ECOSPOR III Study in Recurrent C. Difficile Infection
Published: 2021-09-29 (Crawled : 21:00) - biospace.com/
MCRB | $0.6274 -1.37% -1.39% 4.8M

Health Technology

| -90.83% | O: 0.86% H: 2.57% C: -2.71%
phase 3 injection infections

Mannkind Corporation Announces Sale-Leaseback Transaction Generating $102.25 Million in Non-Dilutive Gross Proceeds
Published: 2021-09-29 (Crawled : 21:00) - globenewswire.com
UTHR | $235.44 1.58% 1.55% 370K

Health Technology

| 24.95% | O: 0.31% H: 0.58% C: -0.8%
MNKD | $4.105 1.36% 1.34% 2.3M

Health Technology

| -9.6% | O: 0.0% H: 1.34% C: -2.9%

Pasithea Therapeutics Corp. to Present at the Benzinga Healthcare Small Cap Conference
Published: 2021-09-29 (Crawled : 21:00) - globenewswire.com
KTTA | $7.25 -1.19% 350

| 153.47% | O: 0.34% H: 9.41% C: 5.92%
conference

IntelGenx and Aquestive Therapeutics Partner with Leading Men’s Health Company to Market Tadalafil Oral Films in the U.S.
Published: 2021-09-29 (Crawled : 21:00) - globenewswire.com
AQST | $3.915 1.69% 1.66% 2.4M

Health Technology

| -12.7% | O: 0.91% H: 0.0% C: -2.02%

Expansion Therapeutics Widens Funding by $80 Million for RNA-Linked Research
Published: 2021-09-29 (Crawled : 17:00) - biospace.com/
SNY | News | $46.125 0.71% 0.7% 3.7M

Health Technology

| -4.24% | O: 1.13% H: 0.93% C: -0.14%
funding expansion research

NeuroSense Therapeutics announces the appointment of Mark Leuchtenberger as Chairman of the Board
Published: 2021-09-29 (Crawled : 15:00) - biospace.com/
XBIO | $4.015 -4.09% 2.8K

Health Technology

| 96.81% | O: 0.0% H: 3.43% C: -1.96%
BIIB | $192.13 -1.55% -1.57% 1.3M

Health Technology

| -31.46% | O: 0.37% H: 1.25% C: -0.07%

Results Show Long-Lasting and Holistic Improvements in Children with AADC Deficiency Treated with PTC-AADC Gene Therapy
Published: 2021-09-29 (Crawled : 14:00) - biospace.com/
PTCT | News | $25.19 -0.4% -0.4% 670K

Health Technology

| -33.97% | O: 0.44% H: 1.72% C: -3.69%
gene therapy therapy results children gene therapies

Helsinn Group and BridgeBio Pharma’s Affiliate QED Therapeutics Announce Health Canada Conditional Approval of TRUSELTIQ™ (infigratinib) for Patients with Cholangiocarcinoma
Published: 2021-09-29 (Crawled : 14:00) - biospace.com/
BBIO | $24.98 -1.03% -1.04% 1.7M

Health Technology

| -49.62% | O: 0.38% H: 1.15% C: -5.31%
approval pharma

Kintara Therapeutics Announces Fiscal Year 2021 Financial Results and Provides Corporate Update
Published: 2021-09-29 (Crawled : 14:00) - biospace.com/
KTRA | $0.1038 -3.08% -3.18% 1.8M

Distribution Services

| -87.65% | O: 2.7% H: 0.0% C: -8.37%
financial results results

SCYNEXIS Presents Interim Analysis from FURI at Virtual IDWeek 2021 Showing Favorable Therapeutic Response in Severe Hospital-Based Fungal Infections Treated with Oral Ibrexafungerp Subpopulation analysis
Published: 2021-09-29 (Crawled : 13:15) - biospace.com/
SCYX | $1.42 0.71% 0.7% 130K

Health Technology

| -74.27% | O: 0.73% H: 0.36% C: -3.26%
fungal infections injection infections fungal infection

Denali Therapeutics Announces Upcoming Presentations on EIF2B Activator DNL343 and RIPK1 Inhibitor SAR443820/DNL788 at the 2021 Annual Northeast Amyotrophic Lateral Sclerosis (NEALS) Meeting
Published: 2021-09-29 (Crawled : 13:15) - globenewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M

Health Technology

| -4.24% | O: 1.13% H: 0.93% C: -0.14%
DNLI | $16.81 -3.06% -3.15% 1.4M

Health Technology

| -65.69% | O: 0.22% H: 0.73% C: -2.43%
presentation sclerosis

Cidara Therapeutics to Present New Data for Rezafungin at TIMM Congress
Published: 2021-09-29 (Crawled : 13:00) - globenewswire.com
CDTX | $0.73 0.0% 420K

Health Technology

| -67.41% | O: 0.45% H: 1.33% C: -0.89%

Sporos Bioventures Appoints Amit Rakhit, M.D. as Chief Executive Officer
Published: 2021-09-29 (Crawled : 13:00) - biospace.com/
OVID | $3.12 -1.58% -1.6% 160K

Health Technology

| -7.04% | O: 0.88% H: 0.0% C: -3.78%

Scopus BioPharma's Subsidiary — Duet Therapeutics — Announces Release of Preclinical Data Being Presented at 17th Annual Meeting of the Oligonucleotide Therapeutics Society
Published: 2021-09-29 (Crawled : 13:00) - globenewswire.com
SCPS | $0.1682

| -91.5% | O: -0.5% H: 10.3% C: 0.75%
biopharma leo preclinical pre-clinical

SCYNEXIS Presents Interim Analysis from FURI at Virtual IDWeek 2021 Showing Favorable Therapeutic Response in Severe Hospital-Based Fungal Infections Treated with Oral Ibrexafungerp
Published: 2021-09-29 (Crawled : 13:00) - globenewswire.com
SCYX | $1.42 0.71% 0.7% 130K

Health Technology

| -74.27% | O: 0.73% H: 0.36% C: -3.26%
fungal infections injection infections fungal infection

Enlivex to Present at Reuters Events' Cell & Gene Therapy USA 2021
Published: 2021-09-29 (Crawled : 13:00) - globenewswire.com
ENLV | $1.47 1.38% 1.36% 390K

Health Technology